Case Report
Systemic Lupus Erythematosus and Antiphospholipid Syndrome Accompanied by Mixed-Type Autoimmune Hemolytic Anemia
Table 1
Laboratory findings on admission.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
APTT, activated partial thromboplastin time; FDP, fibrin-fibrinogen degradation product; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LD, lactate dehydrogenase; ALP, alkaline phosphatase; γ-GTP, γ-glutamyl transpeptidase; Na, sodium; K, potassium; Cl, chloride; Ca, calcium; Fe, iron; UIBC, unsaturated iron-binding capacity; TIBC, total iron-binding capacity; TSH, thyroid-stimulating hormone; T4, thyroxine; sIL-2R, soluble interleukin-2 receptor; BNP, brain natriuretic peptide; CRP, C-reactive protein; Ig, immunoglobulin; C3, third component of complement; C4, fourth component of complement; Ab, antibodies; CLβ2GP1, cardiolipin β2 glycoprotein I; HBV, hepatitis B virus; HCV, hepatitis C virus; HTLV-1, human T-cell leukemia virus type-1. Numbers in parentheses indicate reference range. |